| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Call for justice-informed HIV cure trials with ATIs
|
Dubé, Karine
|
|
|
11 |
3 |
p. e137-e139
|
artikel
|
| 2 |
Centring the health of women across the HIV research continuum
|
Barr, Elizabeth
|
|
|
11 |
3 |
p. e186-e194
|
artikel
|
| 3 |
Disparities in approaches to ART access in Europe
|
Tribaudeau, Laure
|
|
|
11 |
3 |
p. e140
|
artikel
|
| 4 |
Drug consumption room comes to Glasgow
|
Holt, Ed
|
|
|
11 |
3 |
p. e143-e144
|
artikel
|
| 5 |
HIV and people who inject drugs: inequality until death
|
Seguin-Devaux, Carole
|
|
|
11 |
3 |
p. e136-e137
|
artikel
|
| 6 |
HIV self-testing, PrEP, and drug resistance: some insights
|
Ochieng, Walter
|
|
|
11 |
3 |
p. e134-e136
|
artikel
|
| 7 |
Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling study
|
Cox, Sarah N
|
|
|
11 |
3 |
p. e167-e175
|
artikel
|
| 8 |
Lenacapavir plus two bNAbs: feasible, with some caveats
|
Martinez, Esteban
|
|
|
11 |
3 |
p. e132-e133
|
artikel
|
| 9 |
Living authentically despite prejudice and marginalisation
|
Burki, Talha
|
|
|
11 |
3 |
p. e145
|
artikel
|
| 10 |
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
|
Trickey, Adam
|
|
|
11 |
3 |
p. e176-e185
|
artikel
|
| 11 |
Response to Thailand's commitment to support community-led HIV services
|
Phanuphak, Nittaya
|
|
|
11 |
3 |
p. e141-e142
|
artikel
|
| 12 |
Retiring the term AIDS for more descriptive language
|
Núñez, Isaac
|
|
|
11 |
3 |
p. e195-e198
|
artikel
|
| 13 |
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
|
Eron, Joseph J
|
|
|
11 |
3 |
p. e146-e155
|
artikel
|
| 14 |
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
|
Moyle, Graeme
|
|
|
11 |
3 |
p. e156-e166
|
artikel
|
| 15 |
Thailand's commitment to support community-led HIV services
|
Lertpiriyasuwat, Cheewanan
|
|
|
11 |
3 |
p. e141
|
artikel
|
| 16 |
The role of HIV biology in defining virological failure
|
Boyce, Ceejay L
|
|
|
11 |
3 |
p. e133-e134
|
artikel
|
| 17 |
Women lead the way in the HIV response
|
The Lancet HIV,
|
|
|
11 |
3 |
p. e131
|
artikel
|
Tijdschrift beschrijving